Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Segment Highlights
STE logo

STERIS Revenue Climbs 5.6% to $1.37B on Recurring Growth and Divestitures

STE10-QFiling Date: 2/7/2025
STERIS plc
Description

What this story covers

STERIS plc reported Q3 revenue of $1.37 billion, up 5.6%, driven by organic growth in Healthcare and AST segments amid Dental divestiture. Operating income rose 8.3%, cash flow surged 24% to $887 million, enabling debt reduction to $2.16 billion. Strategic shifts boost recurring revenues to over 70%, with margins expanding despite costs. Risks include regulations and supply chains, managed via hedges.

Story snapshot

CompanySTERIS plc
TickerSTE
VariantStandard detailed
Duration12:32
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001757898-25-000002

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in